In this episode, Jona Tanguay, MMSc, PA-C, AAHIVS discusses considerations to review with patients to empower them to make their own informed choices in PrEP selection, including:

• Leveraging PrEP options with unique dosing schedules and/or routes such as long-acting cabotegravir and on-demand 2-1-1 FTC/TDF
• Differences in adverse effect profiles between 4 PrEP options
• Potential for HIV resistance
• Requirements for compliance and monitoring
• Evidence in populations with various acquisition behaviors
• Drug interaction implications

 

Faculty: 

Jona Tanguay, MMSc, PA-C, AAHIVS

Health Care Provider and HIV Specialist 

Whitman-Walker Health

Vice President for Education, GLMA: Health Professionals Advancing LGBTQ Equality

Clinical Instructor, Yale University School of Nursing 

Washington, DC

 

Link to full program: https://bit.ly/41WF54o

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.